Subsequent studies showed that BRAF mutation frequency ranges from 28 to 54% of analyzed melanoma samples depending on the analyzed group of patients, biological material, and technique (Ticha et al. 2019; Diefenbach et al. 2020). Here, BRAF is linked to melanoma.